GoodRx (GDRX) Offers Foundayo GLP-1 Medication for $149 Monthly
Published on · Source: investing.com
AI Summary
Summarized by AI from the source belowGoodRx (GDRX) has announced that it will offer the Foundayo GLP-1 medication starting at a price of $149 per month. This move provides a lower-cost option for patients seeking weight management treatments. The availability of this medication may impact the market for weight-loss pharmaceuticals by introducing competition. As healthcare costs continue to be a focus for consumers and providers, this pricing could influence purchasing decisions in the sector.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
